Richard A Miller MD
CIK 1031847 · View on SEC EDGAR ↗
First SEC filing: Feb. 10, 2017 · Latest: Feb. 4, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2019 | CRVS | P | 2,500 | $3.54 | $8,850 | 1,163,507 Indirect | +0.22% | Acquired | 311.7% (price as of 2026-08-21) |
| Aug. 6, 2019 | CRVS | P | 5,000 | $3.58 | $17,900 | 1,161,007 Indirect | +0.43% | Acquired | 307.1% (price as of 2026-08-21) |
| June 14, 2019 | CRVS | P | 11,657 | $3.40 | $39,634 | 1,156,007 Indirect | +1.02% | Acquired | 328.7% (price as of 2026-08-21) |
| June 13, 2019 | CRVS | P | 343 | $3.52 | $1,207 | 1,144,350 Indirect | +0.03% | Acquired | 314.1% (price as of 2026-08-21) |
| Dec. 27, 2018 | CRVS | P | 20,000 | $3.29 | $65,800 | 1,128,795 Indirect | +1.80% | Acquired | 343.0% (price as of 2026-08-21) |
| Dec. 20, 2018 | CRVS | P | 5,000 | $4.39 | $21,950 | 1,108,795 Indirect | +0.45% | Acquired | 232.0% (price as of 2026-08-21) |
| Dec. 20, 2018 | CRVS | P | 5,000 | $4.40 | $22,000 | 1,103,795 Indirect | +0.46% | Acquired | 231.3% (price as of 2026-08-21) |
| Dec. 6, 2018 | CRVS | P | 5,000 | $5.99 | $29,950 | 1,118,795 Indirect | +0.45% | Acquired | 143.3% (price as of 2026-08-21) |
| Dec. 4, 2018 | CRVS | P | 1,502 | $5.95 | $8,937 | 1,113,795 Indirect | +0.14% | Acquired | 145.0% (price as of 2026-08-21) |
| March 12, 2018 | CRVS | P | 100,000 | $8.50 | $850,000 | 1,112,293 Indirect | +9.88% | Acquired | 71.5% (price as of 2026-08-21) |
| Nov. 20, 2017 | CRVS | P | 10,000 | $10.78 | $107,800 | 1,012,293 Indirect | +1.00% | Acquired | 35.2% (price as of 2026-08-21) |
| June 13, 2017 | CRVS | P | 2,500 | $10.14 | $25,350 | 1,002,293 Indirect | +0.25% | Acquired | 43.7% (price as of 2026-08-21) |
| June 13, 2017 | CRVS | P | 2,500 | $9.75 | $24,375 | 999,793 Indirect | +0.25% | Acquired | 49.5% (price as of 2026-08-21) |
| June 12, 2017 | CRVS | P | 11,216 | $9.82 | $110,141 | 997,293 Indirect | +1.14% | Acquired | 48.4% (price as of 2026-08-21) |
| June 9, 2017 | CRVS | P | 3,784 | $9.89 | $37,424 | 986,077 Indirect | +0.39% | Acquired | 47.4% (price as of 2026-08-21) |
| June 9, 2017 | CRVS | P | 5,000 | $9.95 | $49,750 | 982,293 Indirect | +0.51% | Acquired | 46.5% (price as of 2026-08-21) |
| May 13, 2016 | CRVS | P | 300 | $9.94 | $2,982 | 1,077,293 Indirect | +0.03% | Acquired | 46.6% (price as of 2026-08-21) |
| May 12, 2016 | CRVS | P | 30,000 | $10.00 | $300,000 | 1,076,993 Indirect | +2.87% | Acquired | 45.8% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 12, 2023 | BOLT | Stock Option (Right to Buy) | Common Stock (25,000) | $1.63 | June 11, 2033 | 25,000 | Acquired |
| March 31, 2023 | CRVS | Stock Option (Right to Buy) | Common Stock (800,000) | $0.91 | March 31, 2033 | 800,000 | Acquired |
| Dec. 14, 2022 | BOLT | Stock Option (Right to Buy) | Common Stock (25,000) | $1.36 | Dec. 13, 2032 | 25,000 | Acquired |
| June 10, 2022 | BOLT | Stock Option (Right to Buy) | Common Stock (25,000) | $1.99 | June 9, 2032 | 25,000 | Acquired |
| March 24, 2022 | BOLT | Stock Option (Right to Buy) | Common Stock (25,000) | $3.03 | March 23, 2032 | 25,000 | Acquired |
| Dec. 12, 2018 | CRVS | Stock Option (Right to Buy) | Common Stock (250,000) | $5.94 | Dec. 12, 2028 | 250,000 | Acquired |
| Dec. 13, 2017 | CRVS | Stock Option (Right to Buy) | Common Stock (125,000) | $10.60 | Dec. 13, 2027 | 125,000 | Acquired |
| Dec. 7, 2016 | CRVS | Stock Option (Right to Buy) | Common Stock (160,000) | $16.37 | Dec. 7, 2026 | 160,000 | Acquired |
| March 29, 2016 | CRVS | Series B Preferred Stock | Common Stock (62,455) | — | — | 62,455 | Disposed |
| March 29, 2016 | CRVS | Series A Preferred Stock | Common Stock (266,310) | — | — | 266,310 | Disposed |
| March 22, 2016 | CRVS | Stock Option (Right to Buy) | Common Stock (500,000) | $15.00 | March 22, 2026 | 500,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Feb. 4, 2021 | BOLT | Common Stock | 15,602 | Direct |
| Feb. 4, 2021 | BOLT | Stock Option (Right to Buy)→ Common Stock (10,808) | 10,808 | Direct |
| March 22, 2016 | CRVS | Common Stock, $0.0001 par value | — | Indirect |
| March 22, 2016 | CRVS | Series A Convertible Preferred Stock→ Common Stock (266,310) | 266,310 | Indirect |
| March 22, 2016 | CRVS | Series B Convertible Preferred Stock→ Common Stock (62,455) | 62,455 | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $301,837 | — | — | $948,765 | — | — | $2,000 | $1,252,602 |
| 2016 | $291,770 | — | — | $7,246,296 | — | — | — | $7,538,066 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.